Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Deferred Taxes (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Deferred Taxes for 16 consecutive years, with $100000.0 as the latest value for Q4 2025.

  • Quarterly Deferred Taxes fell 50.0% to $100000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 million through Dec 2025, up 60.71% year-over-year, with the annual reading at $100000.0 for FY2025, 103.57% up from the prior year.
  • Deferred Taxes for Q4 2025 was $100000.0 at Myriad Genetics, down from $200000.0 in the prior quarter.
  • The five-year high for Deferred Taxes was $600000.0 in Q1 2024, with the low at -$16.3 million in Q3 2021.
  • Average Deferred Taxes over 5 years is -$4.1 million, with a median of -$2.2 million recorded in 2024.
  • The sharpest move saw Deferred Taxes tumbled 1666.67% in 2022, then soared 500.0% in 2024.
  • Over 5 years, Deferred Taxes stood at -$4.3 million in 2021, then crashed by 104.65% to -$8.8 million in 2022, then skyrocketed by 73.86% to -$2.3 million in 2023, then skyrocketed by 108.7% to $200000.0 in 2024, then tumbled by 50.0% to $100000.0 in 2025.
  • According to Business Quant data, Deferred Taxes over the past three periods came in at $100000.0, $200000.0, and -$1.4 million for Q4 2025, Q4 2024, and Q3 2024 respectively.